Dose Finding Trial of Rosuvastatin and Atorvastatin Versus Hepatitis C

Phase 2CompletedNCT00446940

Bader, Ted, M.D.16 enrolled

Overview

Different Doses of rosuvastatin and atorvastatin will be used to see if HCV viral load changes and liver tests change.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Sex: ALLMin age: 18 YearsMax age: 75 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Hepatitis C Exclusion Criteria: * HIV positivity

VA Hospital

Oklahoma City, Oklahoma, United States

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.